Table 1 |
||||||
|
Results of the hormonal measurements in serum, EDTA-treated and citrated-treated plasma (median and range) by IFMA assays. (p < 0.05) |
||||||
|
IFMA |
||||||
|
|
||||||
|
SERUM |
EDTA |
CITRATE |
||||
|
|
||||||
|
median |
range |
median |
range |
median |
range |
|
|
LH spec IU/L |
5.9 |
0.07–54 |
5.6 |
0.06 -51 |
5.13 |
0.06 -49 |
|
FSH IU/L |
6.8 |
0.02–119 |
6.55 |
0.01–108 |
5.83 |
0.01–94 |
|
PRL ng/mL |
5.53 |
1.6–171 |
5.2 |
1.4–152 |
4.6 |
1.2–137 |
|
GH ng/mL |
0.18 |
0.02–2.4 |
0.03*a |
0.01–4.7 |
0.11a |
0.01–8.2 |
|
INS μIU/mL |
6.95 |
2.3–27 |
< 4.8*# |
<4.8 |
4.8* |
0.2–11 |
|
CPEP ng/mL |
1.78 |
0.7–8.3 |
0.39*a |
0.2–1.7 |
1.13a |
0.4–4.9 |
|
SHBG nmol/L |
47.1 |
14–367 |
28.6* |
8.3–315 |
37.5 |
11–336 |
|
TSH μIU/mL |
1.46 |
0.03–100 |
0.03*a |
0.02–0.28 |
0.45*a |
0.01–53 |
|
|
||||||
|
range refers to minimum and maximum values * statistical significant difference between EDTA or citrate plasma results and serum (p < 0.05) a statistical significant difference between EDTA and citrate plasma results (p < 0.05) # Insulin in EDTA samples was undetectable. |
||||||
|
Kohek et al. BMC Clinical Pathology 2002 2:2 doi:10.1186/1472-6890-2-2 |
||||||